Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · Real-Time Price · USD

4.660

-0.040 (-0.85%)

At close: Feb 27, 2026, 4:00 PM EST

4.630

-0.030 (-0.64%)

After-hours: Feb 27, 2026, 6:05 PM EST

Arbutus Biopharma Employees

Arbutus Biopharma had 44 employees as of December 31, 2024. The number of employees decreased by 29 or -39.73% compared to the previous year.

Employees

Change (1Y)

-29

Growth (1Y)

-39.73%

Revenue / Employee

$331,955

Profits / Employee

-$960,841

Market Cap

896.23M

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2024	44	-29	-39.73%
Dec 31, 2023	73	-25	-25.51%
Dec 31, 2022	98	11	12.64%
Dec 31, 2021	87	9	11.54%
Dec 31, 2020	78	-2	-2.50%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Company Name	Employees
Fortrea Holdings	14,500
AbCellera Biologics	596
Maravai LifeSciences Holdings	550
Arvinas	430
Xencor	250
ARS Pharmaceuticals	167
Cullinan Therapeutics	111
Janux Therapeutics	109